A Double-Blind, Phase I, Single Ascending Dose Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of BOS161721 in Healthy Subjects.

Autor: Hussaini A; PAREXEL International Corporation, Waltham, Massachusetts, USA., Mukherjee R; Cytel, Cambridge, Massachusetts, USA., Berdieva DM; Boston Pharmaceuticals, Cambridge, Massachusetts, USA., Glogowski C; Boston Pharmaceuticals, Cambridge, Massachusetts, USA., Mountfield R; Boston Pharmaceuticals, Cambridge, Massachusetts, USA., Ho PTC; Boston Pharmaceuticals, Cambridge, Massachusetts, USA.

Publikováno v: Clinical and translational science [Clin Transl Sci] 2020 Mar; Vol. 13 (2), pp. 337-344. Date of Electronic Publication: 2019 Nov 29.

PRS40 Cost-Utility of Fluticasone Compared with Beclomethasone and Budesonid in Chronic Obstructive Pulmonary Disease (COPD) in Poland

Autor: Bolisega, D., Dziewiatka, M., Fedyna, M., Ziobro, M., Rutkowski, J., Haldas, M., Barlog, D., Dziurda, D., Glogowski, C., Rys, P., Plisko, R.

Publikováno v: In Value in Health 2011 14(7):A494-A494

PCV35 THE BUDGET IMPACT ANALYSIS OF AMBRISENTAN IN 2ND LINE TREATMENT OF ADULT PATIENTS WITH IDIOPATHIC, FAMILIAR OR ASSOCIATED WITH CONNECTIVE TISSUE DISEASE PULMONARY HYPERTENSION OF III NYHA STAGE

Autor: Kawalec, P, Holko, P, Krzyzanowska, A, Glogowski, C

Publikováno v: In Value in Health 2010 13(7):A347-A347

PCV113 COST-EFFECTIVENESS OF FONDAPARINUX VS ENOXAPARIN IN EXTENDED PROPHYLAXIS OF VENOUS THROMBOEMBOLISM IN MAJOR ORTHOPEDIC SURGERY IN POLAND

Autor: Kawalec, P, Kuzma, J, Glogowski, C, Krzyzanowska, A

Publikováno v: In Value in Health 2009 12(7):A334-A334

PIN15 COST-EFFECTIVENESS OF AUGMENTIN ES® FOR THE TREATMENT OF PAEDIATRIC ACUTE OTITIS MEDIA (AOM) IN POLAND

Autor: Kawalec, P, Glogowski, C, Cel, M

Publikováno v: In Value in Health 2007 10(6):A440-A440